These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 10838661
21. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide. Reddy S, Yip S, Karanam M, Poole CA, Ross JM. Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865 [Abstract] [Full Text] [Related]
24. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Lüder CG, Algner M, Lang C, Bleicher N, Gross U. Int J Parasitol; 2003 Jul 30; 33(8):833-44. PubMed ID: 12865083 [Abstract] [Full Text] [Related]
26. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy]. Yoshida R, Matsuura T, Hijikawa K, Yanagida H, Kitade H, Takada H, Kwon AH. Gan To Kagaku Ryoho; 2012 Oct 30; 39(10):1575-7. PubMed ID: 23064076 [Abstract] [Full Text] [Related]
29. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells. Holán V, Pindjáková J, Zajícová A, Krulová M, Zelezná B, Matousek P, Svoboda P. Xenotransplantation; 2005 May 30; 12(3):227-34. PubMed ID: 15807773 [Abstract] [Full Text] [Related]
30. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. Son K, Kim YM. Cancer Res; 1995 Dec 01; 55(23):5524-7. PubMed ID: 7585626 [Abstract] [Full Text] [Related]
31. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages. Han YJ, Kwon YG, Chung HT, Lee SK, Simmons RL, Billiar TR, Kim YM. Nitric Oxide; 2001 Dec 01; 5(5):504-13. PubMed ID: 11587565 [Abstract] [Full Text] [Related]
32. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. Saio M, Radoja S, Marino M, Frey AB. J Immunol; 2001 Nov 15; 167(10):5583-93. PubMed ID: 11698429 [Abstract] [Full Text] [Related]
35. Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide. Kadhim S, Penney C, Lagraoui M, Heibein J, Attardo G, Zacharie B, Connolly T, Gagnon L. Int J Immunopharmacol; 2000 Sep 15; 22(9):659-71. PubMed ID: 10884587 [Abstract] [Full Text] [Related]
36. [A case of fluoropyrimidine-resistant recurrent colon cancer successfully treated with weekly administration of irinotecan]. Takashima T, Tayama Y, Nakamura Y, Hirata K. Gan To Kagaku Ryoho; 2010 Apr 15; 37(4):719-21. PubMed ID: 20414034 [Abstract] [Full Text] [Related]
37. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. Pfannes SD, Müller B, Körner S, Bessler WG, Hoffmann P. J Leukoc Biol; 2001 Apr 15; 69(4):590-7. PubMed ID: 11310845 [Abstract] [Full Text] [Related]
38. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, Gardani G, Tancini G, Lissoni P. Anticancer Res; 2003 Apr 15; 23(2C):1951-4. PubMed ID: 12820485 [Abstract] [Full Text] [Related]